Luigi Elio Adinolfi has an M.D. degree. He serves as a Full Professor of internal medicine and Director at the Second University of Naples School of Medicine, Italy. He was Postdoctoral Fellow and Chief at University of Cincinnati, Cincinnati, Ohio, USA. He had stage at the Royal Institute of Tropical Medicine and Hygiene, London, and he was a Visiting Professor at Royal Free Hospital, London, UK. In 1990 he became a Faculty Member at Second University of Naples; in 2006 he worked as a Full Professor of Internal Medicine; in 2008 he was appointed as the Director of Internal Medicine and Chair at Clinic Hospital of Marcianise, Second University of Naples. He studied the pathogenic mechanisms and treatment of intrahepatic cholestasis, the HCV-associated cryoglobulinemia, and the mechanisms of disease progression and treatment of chronic hepatitis B and C. At present the major research focus in the field of hepatology includes the metabolic alterations (steatosis, insulin resistance, diabetes, metabolic syndrome), extrahepatic manifestations, in particular atherosclerosis, the mechanisms of progression of liver damage (oxidative stress, cytokines, apoptosis) associated with chronic HCV infection, the molecular basis of progression of chronic hepatitis B, and the clinical aspects of liver cancer. He is the author of more than 200 scientific publications that received more than 2300 citations. He has published more than 100 chapters on national and international books. Prof. Adinolfi was the author of the textbook Treatment of liver and biliary diseases. He is renowned for his seminal study on the HCV-genotype-related development of hepatic steatosis. He is a member of the editorial board and permanent referee of prestigious international Journals He has personally trained many postdoctoral fellows and students in his research laboratory and medical practice in the field of internal medicine and hepatology.
Biography Updated on 9 June 2012